INTERNATIONAL PATENT: VACARA AB FILES APPLICATION FOR "NOVEL CITRULLINATED PEPTIDES THAT BIND TO ANTI-CITRULLINATED PROTEIN ANTIBODIES (ACPAS) AND THEIR USE IN THE DIAGNOSIS AND PREDICTION OF RHEUMATOID ARTHRITIS"

GENEVA, April 18 -- VACARA AB (Nanna Svartz vag 417165 Solna) filed a patent application (PCT/EP2025/079337) for "NOVEL CITRULLINATED PEPTIDES THAT BIND TO ANTI-CITRULLINATED PROTEIN ANTIBODIES (ACPAS) AND THEIR USE IN THE DIAGNOSIS AND PREDICTION OF RHEUMATOID ARTHRITIS" on Oct 10, 2025. With publication no. WO/2026/078240, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HE, Yibo (Nanna Svartz vag 417165 Solna), SAREILA, Outi Talvikki (Nanna Svartz vag 417165 Solna), MARTINSSON HOLMDAHL, David Rikard (Nanna Svartz vag 41...